KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Opko Health (OPK) Total Debt (2016 - 2025)

Opko Health's Total Debt history spans 16 years, with the latest figure at $256.7 million for Q4 2025.

  • For Q4 2025, Total Debt fell 1.44% year-over-year to $256.7 million; the TTM value through Dec 2025 reached $256.7 million, down 1.44%, while the annual FY2025 figure was $256.7 million, 1.44% down from the prior year.
  • Total Debt reached $256.7 million in Q4 2025 per OPK's latest filing, up from $15.3 million in the prior quarter.
  • In the past five years, Total Debt ranged from a high of $260.4 million in Q4 2024 to a low of $7.9 million in Q3 2023.
  • Average Total Debt over 5 years is $69.5 million, with a median of $23.9 million recorded in 2022.
  • Peak YoY movement for Total Debt: soared 3176.48% in 2024, then crashed 94.09% in 2025.
  • A 5-year view of Total Debt shows it stood at $14.7 million in 2021, then soared by 190.15% to $42.6 million in 2022, then decreased by 17.91% to $35.0 million in 2023, then skyrocketed by 644.03% to $260.4 million in 2024, then decreased by 1.44% to $256.7 million in 2025.
  • Per Business Quant, the three most recent readings for OPK's Total Debt are $256.7 million (Q4 2025), $15.3 million (Q3 2025), and $260.0 million (Q2 2025).